Safety of High-Volume Plasmapheresis in Children With Acute Liver Failure
- PMID: 33633079
- DOI: 10.1097/MPG.0000000000003108
Safety of High-Volume Plasmapheresis in Children With Acute Liver Failure
Abstract
Objectives: Paediatric acute liver failure (P-ALF) is a rare condition and is associated with a high mortality rate. Management of P-ALF aims to stabilise vital organ functions and to remove circulating toxins and provide vital plasma factors that are lacking. High-volume plasmapheresis (HVP) removes protein-bound substances and improves survival in adult ALF. It is unknown if this effect can be extrapolated to P-ALF. The aim of this study is to report the safety and feasibility of HVP in P-ALF.
Methods: Children with P-ALF were offered HVP if bilirubin was higher than 200 μmol/L or if the aetiology was toxic hepatitis. HVP was performed with fresh frozen plasma corresponding to 10% of the body weight on a minimum of 3 consecutive days. Diagnostics, biochemical and clinical data during HVP as well as outcome data after 3 months were collected from 2012 to 2019 and retrospectively analysed.
Results: Sixteen children were treated by HVP and completed at least one series of three treatment sessions with HVP. The only complication seen was an increase in pH > 7.55 in three children within the first 12 hours and was corrected with hydrochloric acid. No bleeding or septic episodes were noted during HVP. Eight children survived without liver transplantation, two survived after successful grafting and a total of six children died. The liver injury unit score between survivors with their own liver and the rest, the two groups was significantly different (P = 0.005).
Conclusion: HVP with fresh frozen plasma is feasible and well tolerated in children with P-ALF. No serious adverse events and no procedure-related mortality were observed.
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Conflict of interest statement
The authors report no conflicts of interest
Comment in
-
High-volume Plasmapheresis in Children With Acute Liver Failure: Another Brick in the Wall in the Current Management?J Pediatr Gastroenterol Nutr. 2021 Jun 1;72(6):786-787. doi: 10.1097/MPG.0000000000003134. J Pediatr Gastroenterol Nutr. 2021. PMID: 33797445 No abstract available.
References
-
- Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148:652–658.
-
- Wendon J, Cordoba J, Dhawan A, et al. European Association for the Study of the Liver. Clinical Practice Guidelines Panel. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol 2017; 66:1047–1081.
-
- Narkewicz MR, Dell Olio D, Karpen SJ, et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr 2009; 155:801.e1–806.e1.
-
- Ng VL, Li R, Loomes KM, et al. Outcomes of children with and without hepatic encephalopathy from the pediatric acute liver failure study group. J Pediatr Gastroenterol Nutr 2016; 63:357–364.
-
- Lutfi R, Abulebda K, Nitu ME, et al. Intensive care management of pediatric acute liver failure. J Pediatr Gastroenterol Nutr 2017; 64:660–670.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical